Hematology Disease Topics & Pathways:
Clinical Trials, Clinical Practice (Health Services and Quality), Workforce
This poster walk would aim to highlight recent advance in use of natural killer (NK) cells for improved cancer therapies. NK cell-based therapies are now being pursued from many sources including cord blood, peripheral blood and iPSCs. There are also agents (Bikes, Trikes, cytokines such as IL15, etc) to stimulate endogenous NK cells that are being developed. This poster walk would highlight both pre-clinical and clinical studies that show the progress in this field.
The following abstracts will be featured in this session:
Using NK-Derived Exosomes to Treat Leukemia, Aladin Samara